Estimated read time 3 min read

FDA grants groundbreaking approval for Casgevy, a revolutionary gene-editing treatment for sickle cell disease

In a monumental stride forward in medical science, the U.S. Food and Drug Administration (FDA) has granted approval for the first gene-editing treatment for sickle [more…]